Screener
Mesa Laboratories MLAB Calibration Solutions — Cost Of Revenue Other
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Mesa Laboratories in its filing.
Tagged under the XBRL concept mlab:CostOfRevenueOther.
The source filing: Mesa Laboratories’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026808
| Three months ended June 30, 2026 | Sterilization and Disinfection Control | Biopharmaceutical Development | Calibration Solutions | Clinical Genomics | Total |
|---|---|---|---|---|---|
| Less | |||||
| Depreciation in cost of revenue | 437 | 78 | 111 | 119 | 745 |
| Amortization in cost of revenue | 121 | 379 | - | 191 | 691 |
| Other cost of revenue (b) | 6,788 | 4,020 | 5,143 | 3,739 | 19,690 |
| Total segment cost of revenue | 7,346 | 4,477 | 5,254 | 4,049 | 21,126 |
| Gross Profit (c) | $17,159 | $7,582 | $8,031 | $6,240 | $39,012 |
| Reconciling items: | |||||
| Operating expense | $31,981 |
Document
FAQ
- What is Mesa Laboratories's calibration solutions — cost of revenue other?
- Mesa Laboratories (MLAB) reported calibration solutions — cost of revenue other of $5.14M in Q2 2026.
- How has Mesa Laboratories's calibration solutions — cost of revenue other changed year-over-year?
- Mesa Laboratories's calibration solutions — cost of revenue other decreased by 1.2% year-over-year, from $5.2M to $5.14M.
- What does calibration solutions — cost of revenue other mean?
- This represents miscellaneous direct costs associated with the Calibration Solutions segment that are not categorized as depreciation, amortization, or standard production labor and materials. It provides visibility into ancillary operational expenses required to support the segment's revenue generation.
Ask your AI about Mesa Laboratories's calibration solutions — cost of revenue other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude